Related Experiment Video
Updated: Feb 5, 2026

Preparation of CD4+ T Cells for Analysis of GD3 and GD2 Ganglioside Membrane Expression by Microscopy
Published on: November 8, 2016
Disialoganglioside GD2 Expression in Pediatric Rhabdomyosarcoma: A Case Series and Review of the Literature
Amanda J Saraf1, Paul S Dickman2, Pooja Hingorani2
1Nationwide Children's Hospital, Columbus, OH.
Abstract:
Rhabdomyosarcoma (RMS) is the most common pediatric soft tissue sarcoma. Despite aggressive therapy, patients with metastatic or relapsed disease experience dismal outcomes and novel therapies are urgently needed. In this study, we evaluated expression of disialoganglioside (GD2), a cell surface antigen with therapeutic implication, in 16 RMS patient samples. Scoring revealed GD2 positivity in 25% of the samples. These data suggest that a small subset of RMS tumors express GD2, which may be a therapeutic target in these patients.
Insights
Rhabdomyosarcoma (RMS), a common pediatric cancer, needs new treatments. This study found disialoganglioside (GD2) in 25% of RMS samples, suggesting it could be a therapeutic target for some patients.
Area of Science:
- Pediatric Oncology
- Cancer Immunology
- Molecular Pathology
Background:
- Rhabdomyosarcoma (RMS) is the most frequent soft tissue sarcoma in children.
- Current treatments for metastatic or relapsed RMS offer poor prognoses, highlighting the need for novel therapeutic strategies.
- Disialoganglioside (GD2) is a cell surface antigen recognized for its potential as a therapeutic target in various cancers.
Observation:
- This research investigated the expression of disialoganglioside (GD2) in a cohort of 16 Rhabdomyosarcoma patient samples.
- GD2 expression was assessed using a scoring system to quantify its presence on tumor cells.
Findings:
- Disialoganglioside (GD2) positivity was detected in 25% of the evaluated Rhabdomyosarcoma samples.
- These findings indicate that a specific subset of pediatric RMS tumors express GD2.
Implications:
- The presence of GD2 in a fraction of RMS tumors suggests its potential utility as a targeted therapeutic agent.
- Further research into GD2-targeted therapies could offer new treatment avenues for patients with Rhabdomyosarcoma, particularly those with advanced or recurrent disease.
More Related Videos
09:21Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
Published on: September 13, 2019
04:33Spinal Hernia Repair and Cauda Equina Repositioning After Lumbar Decompression under Three-Dimensional Microscopy: A Case Report and Literature Review
Published on: November 8, 2024
Related Concept Videos
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Resistors In Series
In a series circuit, the...
Series Resonance
Series and Parallel Capacitors
First, consider capacitors connected in series to a battery. In this configuration, the plate connected to the battery's positive terminal develops a positive charge, while the plate attached to the negative terminal becomes negatively charged. An equal magnitude of charge is induced on the...
Trigonometric Fourier series
The trigonometric Fourier series specifically expresses a periodic function with a defined period T using sine...